- Home
- APVO vs EDBL Comparison
APVO vs EDBL Comparison
Compare APVO & EDBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- EDBL
- Stock Information
- Founded
- APVO 2016
- EDBL 2020
- Country
- APVO United States
- EDBL United States
- Employees
- APVO N/A
- EDBL N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- EDBL Farming/Seeds/Milling
- Sector
- APVO Health Care
- EDBL Consumer Staples
- Exchange
- APVO Nasdaq
- EDBL Nasdaq
- Market Cap
- APVO 3.3M
- EDBL 2.9M
- IPO Year
- APVO N/A
- EDBL 2022
- Fundamental
- Price
- APVO $0.67
- EDBL $1.93
- Analyst Decision
- APVO Strong Buy
- EDBL
- Analyst Count
- APVO 1
- EDBL 0
- Target Price
- APVO $296.00
- EDBL N/A
- AVG Volume (30 Days)
- APVO 8.7M
- EDBL 68.2K
- Earning Date
- APVO 05-07-2025
- EDBL 05-14-2025
- Dividend Yield
- APVO N/A
- EDBL N/A
- EPS Growth
- APVO N/A
- EDBL N/A
- EPS
- APVO N/A
- EDBL N/A
- Revenue
- APVO N/A
- EDBL $13,857,000.00
- Revenue This Year
- APVO N/A
- EDBL $29.56
- Revenue Next Year
- APVO N/A
- EDBL $20.00
- P/E Ratio
- APVO N/A
- EDBL N/A
- Revenue Growth
- APVO N/A
- EDBL N/A
- 52 Week Low
- APVO $0.60
- EDBL $1.82
- 52 Week High
- APVO $51.06
- EDBL $230.00
- Technical
- Relative Strength Index (RSI)
- APVO 30.74
- EDBL 37.66
- Support Level
- APVO $0.60
- EDBL $1.82
- Resistance Level
- APVO $0.80
- EDBL $2.12
- Average True Range (ATR)
- APVO 0.19
- EDBL 0.18
- MACD
- APVO 0.03
- EDBL 0.04
- Stochastic Oscillator
- APVO 6.97
- EDBL 20.87
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About EDBL Edible Garden AG Incorporated
Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.